INSULIN RESISTANCE: CAUSES, SYMPTOMS, TREATMENT AND PREVENTIVE MEASURES
DOI:
https://doi.org/10.55640/Keywords:
insulin resistance, metabolic syndrome, glucose metabolism, hyperinsulinemia, type 2 diabetes, obesity, preventionAbstract
Insulin resistance is one of the most important metabolic disorders in modern medicine and plays a significant role in the development of several chronic diseases, including type 2 diabetes mellitus, obesity, and cardiovascular diseases. This condition is characterized by a decreased sensitivity of body tissues to the hormone insulin, resulting in impaired glucose uptake by cells and elevated blood glucose levels. Over time, the pancreas compensates by producing more insulin, leading to hyperinsulinemia and further metabolic disturbances. The development of insulin resistance is influenced by multiple factors such as genetic predisposition, sedentary lifestyle, excessive caloric intake, obesity, and hormonal imbalance. Clinical manifestations often develop gradually and may remain undetected for long periods, which increases the risk of complications. This article analyzes the main causes, pathophysiological mechanisms, clinical manifestations, diagnostic approaches, treatment strategies, and preventive measures of insulin resistance based on current scientific literature. Particular attention is given to lifestyle modification, dietary regulation, physical activity, and pharmacological treatment as key elements in the management of this condition. Understanding the mechanisms and risk factors associated with insulin resistance is essential for early detection and prevention of metabolic disorders.Downloads
References
1.Reaven, G. (2017). Insulin resistance and metabolic syndrome.
2.DeFronzo, R. (2015). Pathogenesis of type 2 diabetes mellitus.
3.World Health Organization. (2021). Global report on diabetes.
4.Ferrannini, E. (2016). Insulin resistance mechanisms.
5.Shulman, G. (2019). Cellular mechanisms of insulin resistance.
6.Zimmet, P. (2016). Global burden of metabolic diseases.
7.Kahn, S. (2019). Insulin resistance and obesity.
8.Petersen, K. (2018). Causes of insulin resistance.
9.Alberti, K. (2017). Metabolic syndrome definition and treatment.
10.Bray, G. (2018). Obesity and metabolic disorders.
11.Saltiel, A. (2018). Insulin signaling pathways.
12.American Diabetes Association. (2022). Standards of medical care in diabetes.
13.Knowler, W. (2017). Prevention of type 2 diabetes.
14.Wild, S. (2019). Global prevalence of diabetes.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India